Build vs Buy AI Agents in Healthcare: Decision Framework and 3-Year Cost Model (2026)
Digital Growth Lead
Writes about healthcare technology, interoperability, and AI-driven transformation across modern care systems.
Should you build or buy AI agents in healthcare? Buy when the workflow is generic and lives in one system. Build when the agent is your product's differentiator or must act across systems a vendor cannot reach. Most teams choose a hybrid: rent the models and runtime, and own the tools, prompts, evaluations, permissions and audit trail.
The build vs buy AI decision in healthcare is a strategy and risk decision as much as a procurement one, because the control layer is where patient safety, HIPAA accountability and vendor lock-in sit.
Updated October 2026. This guide gives healthtech CTOs, product heads and hospital IT leaders a decision framework, a three-year cost model you can fill in with your own numbers, the security and production costs most estimates leave out, and the questions to ask before you sign or staff up. For hands-on help, see our healthcare AI agent development services.
If you are deciding whether to build or buy a healthcare AI agent
| Your seat | What you are really deciding | What you fear |
|---|---|---|
| CTO or VP Engineering at a healthtech company | Whether the agent is part of the product you sell, and whether your team can run it in production | A six-month build that never leaves pilot; pulling engineers off the roadmap |
| Product head | Speed to market against control over the experience and the data | Shipping a generic vendor agent that competitors can buy too |
| Hospital or health system IT and security lead | Which option your security review, BAA chain and EHR team can approve | PHI flowing to a subprocessor nobody reviewed; an agent writing to the wrong patient record |
| CFO or budget owner | Three-year cost and how predictable it is | Usage-based fees that grow faster than revenue; a build that needs a permanent team |
What "build", "buy" and "hybrid" mean for healthcare AI agents
Buying means a vendor runs the agent and you configure it; building means you own the whole stack; a hybrid rents the models and runtime while you own the control layer. The table shows who owns what under each option.
| Buy (platform or vertical product) | Build (own stack) | Hybrid (split the stack) | |
|---|---|---|---|
| Who owns the model calls and runtime | Vendor | You | Rented (model API, cloud runtime) |
| Who owns tools, prompts, evaluations, permissions, audit trail | Vendor, configured by you | You | You |
| EHR and payer integration | Vendor adapters, where they exist | You build each one | You own the ones that differentiate; rent commodity connectors |
| Time to first production use | Fastest for supported workflows | Slowest | In between |
| Lock-in | Highest: prompts and behavior tune to the vendor | Lowest | Low, if you keep the control layer portable |
| Best for | Generic, single-system work: reminders, simple scheduling, FAQ | The agent is your product | Most healthtech and provider use cases |
The hybrid idea is often summed up as "rent the compute, keep the receipts". In healthcare the receipts are the audit trail, the evaluation sets and the permission rules a regulator, customer or auditor will ask for.
Build vs buy a healthcare AI agent framework: the five-question test
Use the five-question score to start the conversation, after two hard gates. This is Nirmitee's discussion heuristic, not a validated model: the thresholds come from our project experience, and the three-year cost model below overrides the score when the two disagree.
Gate 1, security and access: if your security team cannot approve the PHI path, or the EHR will not grant the access the agent needs, no option is ready until that is solved. Gate 2, team: if nobody can run the agent in production, building is off the table until you hire or partner.
Then score each question from 1 (points to buy) to 5 (points to build), and re-score every six months as your workflow and team change. Choose the first workflow with our healthcare workflow automation guide before you score it.
| Question | 1 = buy | 5 = build |
|---|---|---|
| 1. Is the workflow your differentiator? | Generic; every competitor does it the same way | It is why customers pick you |
| 2. Does the agent act across systems? | One application | EHR, payer portals, your own data and back-office tools |
| 3. How sensitive and proprietary is the data? | Standard FHIR resources the vendor already reads | Custom risk scores, unmapped notes, data you cannot send to a third party |
| 4. Do auditors, customers or regulators need provenance you must control? | Low-risk, read-only, or the vendor exports full audit records | Writes to clinical or billing records, and the vendor cannot export the evidence auditors ask for |
| 5. Do you have engineers who know both healthcare integration and LLM systems? | No | Yes, and they can run it in production |
Under 12: buy. 12 to 17: hybrid. Above 17: build. If question 5 scores 1 or 2 and the others score high, the answer is usually hybrid with a partner rather than a solo build.
Compare build, buy and hybrid for one workflow
In two weeks we score your workflow with your team, price all three options on the same cost lines, review the PHI path, and give you a fixed quote for the build or a clear recommendation to buy. Book a scoping call.
Should we build healthcare AI agents in-house or buy a platform? Three cases
- Appointment reminders and FAQ answers for a clinic group: generic, single-system, low-risk. Buy a product that signs a BAA. See our check of AI agent platforms that sign a HIPAA BAA.
- A prior authorization agent inside an RCM product: differentiating, multi-system, writes to records. Hybrid at least: rent the model, own the payer rules, tools, evaluations and audit trail. Our prior authorization software guide covers the build, buy or partner choice for this case.
- An agent that must work inside an EHR screen with no usable API: few vendors cover your exact EHR and workflow. Build or partner, with strict controls. For EHR-screen execution and recovery, use EHR automation without API access, and compare the approaches in RPA vs agentic AI in healthcare.
The three-year total cost of ownership (TCO) model
Compare build, buy and hybrid on the same three years and the same cost lines; vendor quotes and build estimates are not comparable until they cover the same work. Fill in this model with your own figures. The only default we give is engineering cost, from public data.
| Cost line | Buy | Build | Hybrid |
|---|---|---|---|
| Licence or platform fees | Vendor quote x 3 years, including growth tiers | None | Runtime or orchestration platform, if used |
| Model usage | Often bundled; check per-call or per-conversation fees | Calls per month x tokens per call x provider price | Same as build |
| Integration engineering | Wiring the vendor to your EHR, data and identity | Every tool and adapter | Differentiating tools only |
| Security and compliance review | Vendor review, BAA chain, your integration code | Full review of your stack | Your stack plus rented parts |
| Evaluation and safety testing | Your test cases against the vendor's agent | Your eval suite and harness | Your eval suite |
| Run and maintain | Configuration and prompt tuning | On-call, drift monitoring, model upgrades | Same as build, smaller surface |
| Exit cost | Migrating prompts, data and workflows out | Low | Low if the control layer is portable |
Engineering cost default: the US Bureau of Labor Statistics puts the median software developer wage at $135,980 (May 2025), and wages are about 70% of private-industry compensation cost (June 2026). That gives a loaded cost of about $194,000 per engineer-year, before recruiting and management. Engineers who know healthcare integration and LLM systems usually cost more.
Worked example (estimate, your numbers will differ): a build that needs 3 engineers for 6 months, then 1 engineer to run it from month 7, costs about $291,000 for the build (1.5 engineer-years) plus $97,000 to run it for the rest of year one, then $194,000 a year, so about $776,000 over three years before model usage. Compare that with the vendor's three-year quote plus your integration, review and tuning time. If the two are close, choose on control and lock-in rather than price.
AI agent vendor exit costs
Price the exit before you sign. Leaving a vendor means exporting prompts, policies, evaluation sets and audit records, rebuilding integrations the vendor owned, and re-running security review on the replacement. Ask each vendor what it exports, in which format, and how long the export takes, and put those answers in the contract.
Model usage is the line most often guessed. Work it out: calls per month x average input and output tokens per call x your provider's published per-token price, then add retries and evaluation runs. Our AI agent cost engineering guide shows how to measure and cut it.
Security and production costs that estimates leave out
Security review, permissions, audit, testing and exception handling are costs on every option, and they are the lines most estimates leave out. These are the ones we see missed most.
| Concern | What a buyer must ask | Cost if missed |
|---|---|---|
| PHI paths | Where do prompts, screenshots, logs and model calls go? Is every party covered by a BAA? | A security review that stops go-live, or an unreported disclosure |
| Excessive permissions | Does the agent run with the least privilege for each tool? Can it write where it only needs to read? | One bad action at scale |
| Prompt injection | Can text in a referral, email or web page change what the agent does? | Data leakage or unauthorized actions |
| Wrong-record writes | Is patient identity verified by code, not by the model, before every write? | Clinical or billing errors that are hard to unwind |
| Repeatability | Do identical inputs give the same final record state? Is there a regression suite? | Results that change while the code stands still |
| Audit trail | Can you show who or what accessed or changed a record, when and why? | Failed audits; no way to investigate incidents |
| Ownership of failures | Who works the exception queue, and how fast? | A silent backlog |
The HIPAA Security Rule requires access controls, audit controls, integrity and authentication safeguards for electronic PHI (HHS), and OWASP's work on agentic AI lists identity, excessive agency and prompt injection among the main risks (OWASP GenAI Security Project). A vendor's BAA covers the vendor's infrastructure, not your integration code, so these controls are your cost on every option. Our guides on building HIPAA-compliant AI agents, agent audit trails and testing healthcare AI agents go deeper.
What to keep in-house even when you buy
- Evaluation sets: your own test cases, with expected final states, so you can compare vendors and catch regressions.
- Permission rules and action allowlists: which tools the agent may call, for which patients and roles.
- The audit trail: a copy of every request, action and outcome in your own store.
- Prompts and policies: versioned, exportable, so a switch does not mean starting again.
- Patient matching and write checks: deterministic code that confirms identity and state before and after each write.
A portability test we suggest: could you move this knowledge to another vendor in about 30 days? If not, own it or keep a portable copy. Treat 30 days as a target to negotiate, since few vendors publish their real export times.
Common build vs buy pitfalls
- Assuming the vendor handles HIPAA. The vendor's BAA covers their infrastructure. Your integration code, logs and access rules still need review.
- Building because "it is cheaper long term". The math only works if engineering time is free. Count the roadmap work you will not ship while the team builds.
- Signing a long contract during evaluation. Run a paid pilot against your own evaluation set first, then commit.
- Skipping "should this be an agent at all?". Many workflows are better served by a rules engine or plain automation. See when not to use an AI agent.
- Treating the pilot as the product. Pilots skip the exception queue, monitoring and on-call. See the scale-up traps after a successful pilot.
How we help teams decide and build
We start with one workflow and the evidence: the systems it touches, the data it needs, the actions it takes and what goes wrong today. We score it on the five questions with your team, price the three options with the same cost lines, and test the riskiest assumption first, usually EHR write access or PHI flow. When the answer is build or hybrid, we separate the agent's interpretation from its authority: the model reads and proposes, while patient matching, permissions, action allowlists and state checks run in code we test like any other software.
Our engineering is public where we can make it public: a desktop computer-use proof of concept with operator review and synthetic healthcare data, a headless FHIR R4 EHR with SMART on FHIR and attribute-based access control, and Da Vinci PAS and CRD servers that pass the Inferno test suites. We are ISO 27001:2022 certified and sign BAAs.
Build-vs-buy decision workshop for one healthcare AI agent
For healthtech and provider teams choosing between a platform, an in-house build and a hybrid for a specific workflow.
- The five-question score for your workflow, agreed with your team.
- A three-year cost comparison of buy, build and hybrid on the same cost lines.
- A security and data-flow review: PHI paths, BAA chain, permissions and audit trail.
- A fixed-price quote for the build, or a clear recommendation to buy and what to keep in-house.
Two weeks. You get a fixed quote after a short scoping call. Book a scoping call. See our healthcare AI solutions.
When the workshop picks an option, our healthcare product discovery services turn it into a scoped implementation plan.
Key takeaways
- Buy generic, single-system workflows. Build when the agent is your product. Most teams land on hybrid.
- Whatever you choose, own the control layer: evaluations, permissions, prompts, audit trail and patient matching.
- Compare three-year costs on the same lines; engineering runs about $194,000 per engineer-year loaded at the BLS median.
- Security and production work is your cost on every option, because a vendor's BAA does not cover your integration.
- Re-score the decision every six months.
For the wider picture, read our pillar on AI agents in healthcare and the agentic AI vendor landscape for 2026.
Ready to scale?
Talk to our healthcare engineering team about building, integrating, and shipping faster.
Frequently Asked Questions
Should we build healthcare AI agents in-house or buy a platform?
Build vs. buy a healthcare AI agent framework: how do I decide?
How much does it cost to build an AI agent for healthcare?
Is buying an AI agent platform always cheaper than building?
When does buying an AI agent cost more than building?
What is a hybrid build and buy approach for AI agents?
Does a vendor's BAA make my AI agent HIPAA compliant?
What should we keep in-house if we buy an AI agent platform?
